Ziraat Times News Desk
Delhi — In a major boost to India’s healthcare innovation, Swiss artificial intelligence (AI) healthcare pioneer Emeralgo AI, through its parent company Computer Vision AG, has signed a memorandum of understanding (MoU) with Delhi-based women-led startup Mc&Me Techserve Pvt. Ltd to establish an AI-driven diagnostics venture in India.
The collaboration, spearheaded by Stefan Voser, Chief Operating Officer of Emeralgo AI, and Pallavi Mehta, Managing Director of Mc&Me Techserve, will involve an investment of about €25 million (₹225 crore). The venture will see Emeralgo holding a 76% stake, while Mc&Me will contribute the remaining 24%.
According to projections, the initiative aims to generate revenues of nearly ₹300 crore by the third year of operations, with an anticipated 30% year-on-year growth thereafter.
Key focus areas of the partnership include:
-
AI-powered Diagnostics: Introduction of advanced AI-enabled MRI and diagnostic software across hospitals and diagnostic centers in India.
-
Rural Healthcare: Delivery of affordable AI-based healthcare solutions for rural populations, particularly targeting economically weaker sections.
-
Employment Opportunities: Training and hiring of more than 500 data analysts within three years.
-
Research & Development: Establishment of an R&D hub and a data center to develop AI tools in cardiology and oncology.
-
Sustainability: Commitment to scalable, innovative, and accessible healthcare models for India.
